Squarepoint’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.48M | Sell |
723,321
-41,577
| -5% | -$373K | 0.01% | 709 |
|
|
2025
Q1 | $5.74M | Buy |
764,898
+405,017
| +113% | +$3.04M | 0.01% | 718 |
|
|
2024
Q4 | $2.71M | Buy |
359,881
+345,729
| +2,443% | +$2.6M | ﹤0.01% | 1029 |
|
|
2024
Q3 | $108K | Buy |
+14,152
| New | +$108K | ﹤0.01% | 2325 |
|
|
2024
Q2 | – | Sell |
-97,614
| Closed | -$496K | – | 2498 |
|
|
2024
Q1 | $496K | Sell |
97,614
-223,060
| -70% | -$1.13M | ﹤0.01% | 1670 |
|
|
2023
Q4 | $1.92M | Sell |
320,674
-425,428
| -57% | -$2.55M | ﹤0.01% | 1045 |
|
|
2023
Q3 | $5.28M | Buy |
746,102
+726,378
| +3,683% | +$5.14M | 0.01% | 582 |
|
|
2023
Q2 | $139K | Sell |
19,724
-131,051
| -87% | -$923K | ﹤0.01% | 2153 |
|
|
2023
Q1 | $1.26M | Sell |
150,775
-126,966
| -46% | -$1.06M | 0.01% | 1054 |
|
|
2022
Q4 | $3.19M | Buy |
277,741
+103,574
| +59% | +$1.19M | 0.01% | 614 |
|
|
2022
Q3 | $2.2M | Buy |
+174,167
| New | +$2.2M | 0.01% | 752 |
|
|
2022
Q2 | – | Sell |
-303,008
| Closed | -$4.93M | – | 2131 |
|
|
2022
Q1 | $4.93M | Buy |
303,008
+254,642
| +526% | +$4.14M | 0.02% | 490 |
|
|
2021
Q4 | $670K | Buy |
+48,366
| New | +$670K | ﹤0.01% | 1436 |
|
|
2021
Q2 | – | Sell |
-56,770
| Closed | -$577K | – | 2616 |
|
|
2021
Q1 | $577K | Buy |
56,770
+34,615
| +156% | +$352K | ﹤0.01% | 1431 |
|
|
2020
Q4 | $165K | Buy |
22,155
+10,755
| +94% | +$80.1K | ﹤0.01% | 2204 |
|
|
2020
Q3 | $39K | Sell |
11,400
-73,572
| -87% | -$252K | ﹤0.01% | 2226 |
|
|
2020
Q2 | $405K | Sell |
84,972
-2,601
| -3% | -$12.4K | 0.01% | 1402 |
|
|
2020
Q1 | $175K | Sell |
87,573
-531,370
| -86% | -$1.06M | ﹤0.01% | 1511 |
|
|
2019
Q4 | $2.14M | Buy |
618,943
+262,522
| +74% | +$906K | 0.01% | 842 |
|
|
2019
Q3 | $1.02M | Buy |
356,421
+313,308
| +727% | +$897K | 0.01% | 1195 |
|
|
2019
Q2 | $163K | Sell |
43,113
-69,132
| -62% | -$261K | ﹤0.01% | 2076 |
|
|
2019
Q1 | $914K | Buy |
112,245
+65,055
| +138% | +$530K | 0.01% | 1144 |
|
|
2018
Q4 | $381K | Sell |
47,190
-13,421
| -22% | -$108K | ﹤0.01% | 1378 |
|
|
2018
Q3 | $462K | Sell |
60,611
-65,103
| -52% | -$496K | 0.01% | 1333 |
|
|
2018
Q2 | $720K | Buy |
+125,714
| New | +$720K | 0.01% | 1025 |
|
|
2017
Q4 | – | Sell |
-65,389
| Closed | -$343K | – | 2073 |
|
|
2017
Q3 | $343K | Buy |
65,389
+30,390
| +87% | +$159K | 0.01% | 1104 |
|
|
2017
Q2 | $195K | Buy |
34,999
+18,199
| +108% | +$101K | ﹤0.01% | 1305 |
|
|
2017
Q1 | $141K | Sell |
16,800
-18,625
| -53% | -$156K | ﹤0.01% | 1347 |
|
|
2016
Q4 | $224K | Buy |
+35,425
| New | +$224K | 0.01% | 1352 |
|
|
2016
Q2 | – | Sell |
-41,197
| Closed | -$117K | – | 1101 |
|
|
2016
Q1 | $117K | Buy |
41,197
+13,997
| +51% | +$39.8K | 0.01% | 1061 |
|
|
2015
Q4 | $281K | Buy |
+27,200
| New | +$281K | 0.03% | 824 |
|